Zu "417716-92-8" wurden 3 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
Lenvatinib
Lenvatinib

Artikelnummer: Cay19375-5

Lenvatinib is an inhibitor of the receptor tyrosine kinases VEGF receptor 2 (VEGFR2) and VEGFR3 (IC50s = 4 and 5.2 nM, respectively). It also inhibits the related kinases VEGFR1, FGFR1, PDGFRalpha, PDGFRbeta and Kit (IC50s = 22, 46, 51, 39, and 100 nM, respectively). Lenvatinib (30 mg/kg, twice per day) reduces...
Schlagworte: E-7080, ER-203492-00, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide
Anwendung: VEGFR / FGFR / PDGFR inhibitor
CAS 417716-92-8
MW: 426.9 D
ab 43,00 €
Bewerten
Lenvatinib, Free Base
Lenvatinib, Free Base

Artikelnummer: LC-L-5400_1g

Soluble in DMSO. Lenvatinib, also known as E7080, is an active inhibitor of multiple receptor tyrosine kinases, with IC50 values of 22 nM (VEGFR1), 4 nM (VEGFR2), 5.2 nM (VEGFR3), 46 nM (FGFR1), 51 nM (PDGFRa), 39 nM (PDGFRb), and 100 nM (KIT). It inhibited SCF- and VEGF-induced angiogenesis of human umbilical vein...
Schlagworte: E7080, ER20349200
Anwendung: Antineoplastic, Receptor tyrosine kinase inhibitor
CAS 417716-92-8
MW: 426.85 D
ab 83,00 €
Bewerten
E-7080
E-7080

Artikelnummer: SYN-1038-M001

Soluble in DMSO or ethanol. E7080 is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors. It is most potent against VEGFR2(KDR)/VEGFR3(Flt-4), with IC(50) values of 4nM and 5.2nM respectively. Target: FGFR - VEGFR - SCF , Kinase Group: RTK , Substrate: Tyrosine
Schlagworte: E-7080
Anwendung: VEGFR2 /VEGFR3 inhibitor
CAS 417716-92-8
MW: 426,9 D
ab 119,00 €
Bewerten